XML 23 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Redeemable Noncontrolling Interest and Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Convertible Preferred Stock
Class A Common Stock
Redeemable Noncontrolling Interest
Founders Preferred Stock and Convertible Preferred
Founders Preferred Stock and Convertible Preferred
Founders Preferred Stock and Convertible Preferred Stock
Founders Preferred Stock and Convertible Preferred
Convertible Preferred Stock
Common Stock
Common Stock
Class A Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning Balance at Dec. 31, 2018 $ 71,288         $ 174,375     $ 1 $ 13,745 $ (50) $ (116,783)
Beginning balance (in shares) at Dec. 31, 2018           83,890     36,352      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Issuance of series convertible preferred stock, net of issuance costs (in shares)           26,296            
Issuance of series convertible preferred stock, net of issuance costs 124,647         $ 124,647            
Issuance of Series D convertible preferred stock upon exercise of convertible preferred stock warrants (in shares)           421            
Issuance of Series D convertible preferred stock upon exercise of convertible preferred stock warrants 1,500         $ 1,500            
Conversion of founders preferred stock to Class A common stock (in shares)           (11)     11      
Issuance of common stock upon exercise of stock options, net of repurchases (in shares)                 2,570      
Issuance of common stock upon exercise of stock options, net of repurchases 1,432                 1,432    
Vesting of early exercised stock options 597                 597    
Vesting of performance-based convertible preferred stock warrants 625                 625    
Stock-based compensation 9,889                 9,889    
Conversion of convertible preferred stock to common stock in connection with initial public offering (in shares)           1,328            
Conversion of convertible preferred stock to common stock in connection with initial public offering 6,298         $ 6,298            
Accretion adjustments of redeemable noncontrolling interest to redemption value 0   $ 0                  
Other comprehensive income (loss), net 143                   143  
Net income (loss) (81,452)   (48,750)                 (81,452)
Ending balance (in shares) at Dec. 31, 2019           111,924   38,933 38,933      
Ending Balance at Dec. 31, 2019 134,967         $ 306,820   $ 1 $ 1 26,288 93 (198,235)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Issuance of series convertible preferred stock, net of issuance costs (in shares)           9,907            
Issuance of series convertible preferred stock, net of issuance costs 76,247         $ 76,247            
Issuance of Series D convertible preferred stock upon exercise of convertible preferred stock warrants (in shares)           548            
Issuance of Series D convertible preferred stock upon exercise of convertible preferred stock warrants 2,158         $ 2,158            
Exercise of convertible preferred stock warrants (in shares)               2,807        
Exercise of performance-based convertible preferred stock warrants 10,000                 10,000    
Issuance of common stock upon exercise of stock options, net of repurchases (in shares)               6,207        
Issuance of common stock upon exercise of stock options, net of repurchases 4,161                 4,161    
Vesting of early exercised stock options 210                 210    
Vesting of performance-based convertible preferred stock warrants 185                 185    
Stock-based compensation 10,124                 10,124    
Accretion adjustments of redeemable noncontrolling interest to redemption value 0   0                  
Other comprehensive income (loss), net (98)                   (98)  
Net income (loss) (74,617)   (50,131)                 (74,617)
Ending balance (in shares) at Dec. 31, 2020         122,379 122,379   47,948 47,948      
Ending Balance at Dec. 31, 2020 163,337     $ 0 $ 385,225 $ 385,225   $ 1 $ 1 50,968 (5) (272,852)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Issuance of series convertible preferred stock, net of issuance costs (in shares)             22,419   22,468      
Issuance of series convertible preferred stock, net of issuance costs 366,684 $ 309,701         $ 309,701     366,684    
Exercise of convertible preferred stock warrants (in shares)         2,075              
Exercise of performance-based convertible preferred stock warrants 8,014       $ 8,014              
Issuance of common stock upon exercise of stock options, net of repurchases (in shares)                 12,927      
Issuance of common stock upon exercise of stock options, net of repurchases 13,397                 13,397    
Vesting of early exercised stock options 5,023                 5,023    
Vesting of performance-based convertible preferred stock warrants 118                 118    
Vesting of restricted stock units (in shares)                 108      
Stock-based compensation 70,844                 70,844    
Unrealized loss on investments in marketable securities, net (794)                   (794)  
Repayment of employee promissory note collateralized by common stock 2,881                 2,881    
Noncontrolling interest recognized in connection with business combination       33,748                
Conversion of convertible preferred stock to common stock in connection with initial public offering (in shares)         (146,873)       146,873      
Conversion of convertible preferred stock to common stock in connection with initial public offering 0       $ (702,940)       $ 1 702,939    
Issuance of warrant in connection with the Credit Agreement 6,789                 6,789    
Accretion adjustments of redeemable noncontrolling interest to redemption value (1,430)   (1,323) 1,430           (1,430)    
Foreign currency translation loss (9)                   (9)  
Net income (loss) (169,913)   $ (151,901) 771               (169,913)
Ending balance (in shares) at Dec. 31, 2021         0       230,324      
Ending Balance at Dec. 31, 2021 $ 774,642     $ 35,949 $ 0       $ 2 $ 1,218,213 $ (808) $ (442,765)